Several studies demonstrated that the resistance of pancreatic carcinoma cells to chemotherapy is indeed due to their constitutive NF-κB activity rather than a transient induction of NF-κB by different anti-cancer drugs (Arlt et al., 2001). Here, NFKB1 is linked to cancer.